Operating CF
$21.2B
Capex
-$359M
Free Cash Flow
$20.9B
FCF Margin
+98.3%
Cash flow waterfall for AbbVie (ABBV) — TTM through Q1 2026
Free cash flow: $20.9B
Cash flow breakdown for AbbVie (ABBV) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $21.2B | $21.2B |
| Capital Expenditure | -$359M | $20.9B |
| Free Cash Flow | $20.9B | $20.9B |
| Acquisitions | -$827M | $20B |
| Other Investing | -$5.3B | $14.7B |
| Share Buybacks | -$1.5B | $13.2B |
| Dividends Paid | -$11.8B | $1.42B |
| Net Debt Change | $2.63B | $4.05B |
| Other Financing & FX | $165M | $4.22B |
| Net Cash Increase | $4.22B | $4.22B |
- Operating Cash Flow$21.2B
- Capital Expenditure-$359M
- Free Cash Flow$20.9B
- Acquisitions-$827M
- Other Investing-$5.3B
- Share Buybacks-$1.5B
- Dividends Paid-$11.8B
- Net Debt Change$2.63B
- Other Financing & FX$165M
- Net Cash Increase$4.22B
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
How this company returns cash to shareholders — buybacks, dividends, and stock splits.